by Instem Team | Mar 7, 2025 | Clinical
Validation is the foundation of any biostatistics team. Whether facilitating study design, analyzing clinical trial or research study data, or supporting data visualization and interpretation, ensuring data integrity and compliance is essential1,2. However, for new...
by Instem Team | Mar 7, 2025 | Resources
In this white paper, we will explore the role of Standard for Exchange of Nonclinical Data (SEND) in maximizing the efficiency of ICH S1B submissions and provide a structured approach to using structured SEND data to support Weight of Evidence (WoE) for ICH S1B...
by Instem Team | Mar 7, 2025 | Company News
At Instem, we are proud to celebrate International Women’s Day 2025 by highlighting the experiences, challenges, and triumphs of the incredible women in our leadership team. This year’s theme, #AccelerateAction, resonates deeply with us as we continue to...
by Instem Team | Feb 26, 2025 | Company News, Regulatory Submission, SEND
Join the upcoming webinar from the American College of Toxicology (ACT) featuring Marc Ellison, Director, Regulatory Solutions, here at Instem Regulatory submission and SEND compliance are critical in preclinical research – stay ahead with expert insights from...
by Instem Team | Feb 25, 2025 | Regulatory Submission, SEND
A thorough guide to this new SEND standard to help your team be prepared. On March 15, 2025, the Standard for Exchange of Nonclinical Data (SEND) Implementation Guide Genetic Toxicology version 1.0 (SENDIG-GeneTox v1.0) will become a regulatory requirement for in vivo...
